MicroRNA‑21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa

Sun,Haibin; Wang,Panzhi; Zhang,Qiangnu; He,Xiaoyan; Zai,Guozhen; Wang,Xudong; Ma,Mei; Sun,Xiaoli

doi:10.3892/mmr.2016.4863

MicroRNA‑21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa

Authors:
- Haibin Sun
- Panzhi Wang
- Qiangnu Zhang
- Xiaoyan He
- Guozhen Zai
- Xudong Wang
- Mei Ma
- Xiaoli Sun
View Affiliations

Affiliations: Department of Pathology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China, Centre of Medical Journal, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China
Published online on: February 4, 2016 https://doi.org/10.3892/mmr.2016.4863
Pages: 2701-2707

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression levels of microRNA‑21 (miR‑21) are increased in a number of types of solid tumors. However, the association between miR‑21 expression and clinical features of patients with gastric carcinoma, and gastric cancer proliferation, invasion and migration remains to be elucidated. The present study investigated the effect of miR‑21 on the clinical features, proliferation, invasion and migration of gastric cancer and the underlying mechanisms associated with Noxa. Reverse transcription quantitative polymerase chain reaction (RT‑qPCR) was performed to detect the expression levels of miR‑21 and Noxa in samples of gastric cancer tissue and matched, adjacent, non‑tumor tissue. The association between miR‑21 expression and the clinical features of patients with gastric carcinoma, as well as the correlation between the mRNA and protein expression levels of miR‑21 and Noxa were analyzed. SGC‑7901 gastric cancer cells were cultured in vitro and transfected with an miR‑21 mimic. The effect of miR‑21 upregulation on proliferation and the cell cycle was determined using the MTT assay and flow cytometry. In addition, migration and invasion of SGC‑7901 cells were observed using the Transwell assay. The target gene of miR‑21 was identified using bioinformatics software and a dual luciferase reporting system. The effect of miR‑21 upregulation on Noxa expression levels in SGC‑7901 cells was also analyzed by RT‑qPCR and western blotting. Increased levels of miR‑21 expression and decreased levels of Noxa expression were observed in gastric cancer tissue samples when compared with the adjacent non‑tumor tissue samples. An increased miR‑21 expression level was identified as a risk factor for advanced stage gastric cancer, lymph node metastasis and larger primary tumors. Furthermore, the overexpression of miR‑21 inhibited Noxa expression levels in SGC‑7901 cells. Therefore, high levels of miR‑21 expression may induce gastric cancer migration and invasion via the downregulation of Noxa expression.

View Figures

View References

1	Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N: Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
2	Ding YB, Xia TS, Wu JD, Chen GY, Wang S and Xia JG: Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 203:217–221. 2012. View Article : Google Scholar
3	Wang R and Chen XZ: High mortality from hepatic, gastric and esophageal cancers in mainland China: 40 years of experience and development. Clin Res Hepatol Gastroenterol. 38:751–756. 2014. View Article : Google Scholar : PubMed/NCBI
4	Bhattacharyya M, Nath J and Bandyopadhyay S: MicroRNA signatures highlight new breast cancer subtypes. Gene. 556:192–198. 2015. View Article : Google Scholar
5	Rane JK, Scaravilli M, Ylipää A, Pellacani D, Mann VM, Simms MS, Nykter M, Collins AT, Visakorpi T and Maitland NJ: MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets. Eur Urol. 67:7–10. 2015. View Article : Google Scholar
6	Xue Z, Wen J, Chu X and Xue X: A microRNA gene signature for identification of lung cancer. Surg Oncol. 23:126–131. 2014. View Article : Google Scholar : PubMed/NCBI
7	Yu J, Feng J, Zhi X, Tang J, Li Z, Xu Y, Yang L, Hu Z and Xu Z: Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer. Tumour Biol. 36:3221–3229. 2015. View Article : Google Scholar
8	Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, et al: Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. J Natl Cancer Inst. 106:1062014. View Article : Google Scholar
9	Rudner J, Elsaesser SJ, Müller AC, Belka C and Jendrossek V: Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis. Biochem Pharmac. 79:10–20. 2010. View Article : Google Scholar
10	Aikawa T, Shinzawa K, Tanaka N and Tsujimoto Y: Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death. FEBS Lett. 584:681–688. 2010. View Article : Google Scholar : PubMed/NCBI
11	Cheng EHYA, Wei MC, Weiler S, Flavell RA, Mak TW and Lindsten T: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell. 8:705–711. 2001. View Article : Google Scholar : PubMed/NCBI
12	Sobin LH, Gospodarowicz MK and Wittekind C: TNM Classification of Malignant Tumors. 7th Edition. Wiley-Blackwell; Oxford: 2010
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Hong L, Han Y, Zhang Y, Zhang H, Zhao Q, Wu K and Fan D: MicroRNA-21: A therapeutic target for reversing drug resistance in cancer. Expert Opin Ther Targets. 17:1073–1080. 2013. View Article : Google Scholar : PubMed/NCBI
15	Wang Z, Han J, Cui Y, Fan K and Zhou X: Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy. Med Hypotheses. 81:41–43. 2013. View Article : Google Scholar : PubMed/NCBI
16	Halimi M, Parsian H, Asghari SM, Sariri R, Moslemi D, Yeganeh F and Zabihi E: Clinical translation of human microRNA 21 as a potential biomarker for exposure to ionizing radiation. Transl Res. 163:578–584. 2014. View Article : Google Scholar : PubMed/NCBI
17	Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB and Bloomston M: Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res. 184:855–860. 2013. View Article : Google Scholar : PubMed/NCBI
18	Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, et al: Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Journal of Hepatology. 56:167–175. 2012. View Article : Google Scholar
19	Wang ZX, Lu BB, Wang H, Cheng ZX and Yin YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res. 42:281–290. 2011. View Article : Google Scholar : PubMed/NCBI
20	Hsu CC, Wu YC, Farh L, Du YC, Tseng WK, Wu CC and Chang FR: Physalin B from Physalis angulata triggers the NOXA-related apoptosis pathway of human melanoma A375 cells. Food Chem Toxicol. 50:619–624. 2012. View Article : Google Scholar : PubMed/NCBI
21	Nakajima W and Tanaka N: Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1. Biochem Biophys Res Commun. 413:643–648. 2011. View Article : Google Scholar : PubMed/NCBI
22	Huskey NE, Guo T, Evason KJ, Momcilovic O, Pardo D, Creasman KJ, Judson RL, Blelloch R, Oakes SA, Hebrok M and Goga L: CDK1 Inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Reports. 4:374–389. 2015. View Article : Google Scholar : PubMed/NCBI
23	Leal AS, Wang R, Salvador JA and Jing Y: Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells. Bioorg Med Chem. 20:5774–5786. 2012. View Article : Google Scholar : PubMed/NCBI
24	Park SY, Jeong MS and Jang SB: In vitro binding properties of tumor suppressor p53 with PUMA and NOXA. Biochem Biophys Res Commun. 420:350–356. 2012. View Article : Google Scholar : PubMed/NCBI
25	Belmar J and Fesik SW: Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol Ther. 145:76–84. 2015. View Article : Google Scholar :
26	Kuwahara Y, Wei D, Durand J and Weissman BE: SNF5 reex-pression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Mol Cancer Res. 11:251–260. 2013. View Article : Google Scholar : PubMed/NCBI
27	Ehrhardt H, Höfig I, Wachter F, Obexer P, Fulda S, Terziyska N and Jeremias I: NOXA as critical mediator for drug combinations in polychemotherapy. Cell Death Dis. 3:e3272012. View Article : Google Scholar : PubMed/NCBI